Optiver Holding
TWST icon

Optiver Holding’s Twist Bioscience TWST Stock Holding History

Optiver Holding’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8K Buy
329
+210
+176% +$13.7K ﹤0.01% 1291
2026
Q1 		$5.66K Buy
+119
New +$5.33K ﹤0.01% 1375
2025
Q4 		– Sell
-324
Closed -$9.12K – 3013
2025
Q3 		$9.12K Buy
324
+200
+161% +$6.06K ﹤0.01% 1358
2025
Q2 		$4.56K Buy
124
+60
+94% +$2.07K ﹤0.01% 1219
2025
Q1 		$2.51K Buy
+64
New +$2.88K ﹤0.01% 1209

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Optiver Holding's TWST Position: Q2 2026 in Review

Optiver Holding increased its Twist Bioscience (TWST) stake by 176% in Q2 2026, buying an estimated $13.7K and bringing the position to 329 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Optiver Holding first reported a position in TWST in Q1 2025 and has held it in 5 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Optiver Holding held 329 shares of Twist Bioscience worth $33.8K as of Q2 2026.
  • Optiver Holding bought 210 Twist Bioscience shares in Q2 2026, an estimated $13.7K.
  • Twist Bioscience made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1291 holding.
  • Optiver Holding first reported a position in Twist Bioscience in Q1 2025 and has held it in 5 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.